Management of Elevated Alkaline Phosphatase Associated with Acetaminophen Use

Assessment and Management

• For patients with elevated alkaline phosphatase (ALP) associated with acetaminophen use, discontinue acetaminophen immediately and administer N-acetylcysteine (NAC) if there are signs of hepatotoxicity or if acetaminophen overdose is suspected, as recommended by the American Association for the Study of Liver Diseases 1, 2
• Determine if the elevated ALP is of hepatic origin by checking gamma-glutamyl transferase (GGT) and/or ALP isoenzymes to confirm hepatobiliary source, according to the European Association for the Study of the Liver 3, 4
• Obtain a complete medication history to confirm acetaminophen dosage and duration of use, as suggested by the American Association for the Study of Liver Diseases 1, 2
• Check acetaminophen levels, even if the history is unclear, as acetaminophen is a leading cause of acute liver failure, as stated by the American Association for the Study of Liver Diseases 1, 2
• Measure aminotransferases (AST, ALT), total bilirubin, and INR to assess the severity of liver injury, as recommended by the American Association for the Study of Liver Diseases 5
• Acetaminophen is a dose-related toxin; most ingestions leading to acute liver failure exceed 10 g/day, but severe liver injury can occur with doses as low as 3-4 g/day in susceptible individuals, according to the American Association for the Study of Liver Diseases 1, 2
• Discontinue acetaminophen immediately, as recommended by the American Association for the Study of Liver Diseases 1, 2
• For acute overdose within 4 hours of presentation, administer activated charcoal (1 g/kg orally) just prior to starting NAC, as suggested by the American Association for the Study of Liver Diseases 1, 2
• Begin NAC promptly for confirmed acetaminophen overdose with elevated ALP and other liver enzymes, as recommended by the American Association for the Study of Liver Diseases 1, 2, 6
• Oral NAC: 140 mg/kg loading dose followed by 70 mg/kg every 4 hours for 17 doses, as suggested by the American Association for the Study of Liver Diseases 1, 2
• IV NAC: 150 mg/kg loading dose over 15 minutes, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours, as recommended by the American Association for the Study of Liver Diseases 1, 2
• Monitor liver function tests, including ALP, aminotransferases, bilirubin, and INR, as recommended by the American Association for the Study of Liver Diseases 5
• For patients with chronic cholestatic liver disease, an ALP elevation of 2× baseline without clear alternative explanation should prompt accelerated monitoring, according to the European Association for the Study of the Liver 8, 4
• Consider drug interruption/discontinuation for ALP >3× baseline, as suggested by the European Association for the Study of the Liver 4
• Repeated supratherapeutic ingestions (>4 g/day) may result in hepatotoxicity, hepatic failure, and even death, as stated by the American College of Emergency Physicians 6, 7
• Consider NAC administration even if acetaminophen levels are low, as recommended by the American College of Emergency Physicians 6, 7
• Standard acetaminophen toxicity nomograms may not be applicable for repeated supratherapeutic ingestions or in patients with altered metabolism, as noted by the American Association for the Study of Liver Diseases 1, 2
• Low or absent acetaminophen levels do not rule out acetaminophen poisoning if the time of ingestion was remote or unknown, as stated by the American Association for the Study of Liver Diseases 1, 2